Hua Xiang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Candida Albicans

Tyrosine Kinase

Prostate Cancer

Cell Cycle Arrest

Top Venues

Journal of medicinal chemistry

Chemical science

China Pharmaceutical University

China Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University Dec 1o 2003

China

Prof :: Medicinal Chemistry

Education History

China Pharmaceutical University Sep 1o 2000 - Dec 1o 2003

China

PHD :: Medicinal Chemistry

Publications

Si Ha, Guoshun Luo, Hua Xiang
A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives. Journal of medicinal chemistry (2022)
Guoshun Luo, Xin Lin, Antonio Vega-Medina, Maoxu Xiao, Guolong Li, Hanlin Wei, Carlos A Velázquez-Martínez, Hua Xiang
Targeting of the FOXM1 Oncoprotein by E3 Ligase-Assisted Degradation. Journal of medicinal chemistry 64 (23) (2021)
Xinyu Li, Binyu Shi, Yu Teng, Yu Cheng, Huizhu Yang, Jiurong Li, Lianjian Wang, Siying He, Qidong You, Hua Xiang
Design, synthesis and biological evaluation of novel 2-phenyl pyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors. MedChemComm 10 (2) (2019)
Fenghua Kang, Jiayi Zhu, Jianbing Wu, Tian Lv, Hua Xiang, Jide Tian, Yihua Zhang, Zhangjian Huang
O2-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation. Chemical science 9 (34) (2018)